Relationship between endothelial dysfunction and serum homocysteine in patients with coronary lesions

Chinese Medical Sciences Journal

Volumn 20, Issue 1, 2005, Pages 63-66

  Chen, Zhe ^a   Li, Chun Sheng ^a   Zhang, Jian ^a   Pang, Bao Sen ^a   Xia, Cheng Qing ^a   Liu, Xi Feng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Coronary arterial disease; Endothelial cell; Homocysteine

Indexed keywords

ENDOTHELIN 1; HOMOCYSTEINE; NITRATE REDUCTASE; NITRIC OXIDE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; INSTRUMENTATION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; VASCULAR ENDOTHELIUM;

AGED; BIOLOGICAL MARKERS; CELL COUNT; CORONARY ARTERIOSCLEROSIS; ENDOTHELIAL CELLS; ENDOTHELIN-1; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE;

EID: 16844381328     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Del Papa N, Colombo G, Fracchiolla N, et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum 2004;50:1296-304.
2. Haynes WG. Hyperhomocysteinemia, vascular function and atherosclerosis: effects of vitamins. Cardiovasc Drugs Ther 2002;16:391-9.
3. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst (e) ine and risk of myocardial infraction in US physicians. JAMA 1992;268:877-81.
4. Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
5. Cardiovascular Institute of Beijing Medical University. The summary of the meeting about homocysteine and diseases in China. Chin Med J 1999;79:406-10.
6. Van Guldener C, Stehouwer CD. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost 2000;26:281-9.
7. Woo KS, Oiao M, Chook P, et al. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention. J Card Surg 2002;17:432-5.
8. Noto R, Neri S, Molino G, et al. Hyperhomocysteinemia in menopausal hypertension: an added risk factor and a dangerous association for organ damage. Eur Rev Med Pharmacol Sci 2002;6:81-7.
9. Xiao F, Guo J. The measurement and meaning of blood homocysteine. Clin Sci 2000;18:56-7.
10. Takahashi H, Harker LA. Measurement of human endothelial cells in whole blood. Thromb Res 1983;31:1-12.
11. Soysal D, Savas S, Susam I, et al. The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery disease, vascular syndrome x and healthy subjects. Anadolu Kardiyol Derg 2003;3:26-34.
12. Quere I, Hillaire D, Brunschwig C, et al. Effects of homocysteine on actylcholine and adenosine induced vasodilation of pancreatic vascular bed in rats. Br J Pharmacol 1997;122:351-7.